Adimmune Corp. (4142) Reports April 2026 Revenue of NT$23 Million, Up 474.4% YoY

Adimmune Corp. (4142), in the biotechnology and medical industry, announced April 2026 revenue of NT$23 million (NT$22,745,000), a remarkable 474.4% year-on-year increase, highlighting exceptional business performance.
財務報告NQ 0/100出典：PR Times

📋 Article Processing Timeline

  • 📰 Published: April 1, 2026 at 09:00
  • 🔍 Collected: May 12, 2026 at 08:00 (983h 0m after Published)
  • 🤖 AI Analyzed: May 12, 2026 at 12:47 (4h 47m after Collected)
No article body provided for translation.

Back to Newsroom (21)